Pembrolizumab,Lenvatinib,Sunitinib,Everolimus
Merck,Pfizer,eisai
['kcsm,(-skcsm)', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'lenva']
lenvatinib plus pembrolizumab maintains survival benefit in advanced rcc #asco23 #kcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.